On Air Now

Heart FM Mornings

5:30am - 10:00am

Now Playing

Pfizer to Seek U.S. Authorization for Distributing COVID-19 Vaccine to 5-11 Age Group

Pfizer and it's German partner BioNTech will now seek U.S. authorization to distribute their COVID-19 vaccine to the 5-11 age group following a successful Phase 2/3 clinical trial.

UNITED STATES - Pfizer says it's COVID-19 vaccine works for kids between the ages of 5 and 11.

It tested a much lower dose of the vaccine, a third of what's in the average shot now, for the elementary school-aged kids. A report in the Associated Press states the fully vaccinated kids developed coronavirus-fighting antibody levels comparable to those in teenagers and young adults.

Pfizer and its German partner BioNTech will now seek authorization for the 5 to 11 age group in the United States. 

The Pfizer-BioNTech vaccine is already being distributed to anyone over the age of 12 in the United States, Canada and in other countries around the world.

More from Local News

Comments

Add a comment

Log in to the club or enter your details below.
Rating *

Weather

Recently Played